Nothing Special   »   [go: up one dir, main page]

GB0106464D0 - Crystalline therapeutic agent - Google Patents

Crystalline therapeutic agent

Info

Publication number
GB0106464D0
GB0106464D0 GB0106464A GB0106464A GB0106464D0 GB 0106464 D0 GB0106464 D0 GB 0106464D0 GB 0106464 A GB0106464 A GB 0106464A GB 0106464 A GB0106464 A GB 0106464A GB 0106464 D0 GB0106464 D0 GB 0106464D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
crystalline therapeutic
crystalline
agent
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0106464A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0106464A priority Critical patent/GB0106464D0/en
Publication of GB0106464D0 publication Critical patent/GB0106464D0/en
Priority to IL15322601A priority patent/IL153226A0/en
Priority to EEP200300045A priority patent/EE200300045A/en
Priority to NZ523226A priority patent/NZ523226A/en
Priority to DZ013364A priority patent/DZ3364A1/en
Priority to SI200130283T priority patent/SI1305314T1/en
Priority to AU7269001A priority patent/AU7269001A/en
Priority to PL01365133A priority patent/PL365133A1/en
Priority to OA1200300008A priority patent/OA12337A/en
Priority to CZ2003126A priority patent/CZ2003126A3/en
Priority to KR20037001202A priority patent/KR100457937B1/en
Priority to AT01951842T priority patent/ATE286901T1/en
Priority to PT01951842T priority patent/PT1305314E/en
Priority to SK57-2003A priority patent/SK572003A3/en
Priority to MXPA03000856 priority patent/MX233602B/en
Priority to EP01951842A priority patent/EP1305314B1/en
Priority to EA200300079A priority patent/EA004681B1/en
Priority to PCT/IB2001/001280 priority patent/WO2002010171A1/en
Priority to BR0112734-9A priority patent/BR0112734A/en
Priority to DE60108398T priority patent/DE60108398T2/en
Priority to HU0302982A priority patent/HUP0302982A3/en
Priority to ES01951842T priority patent/ES2231521T3/en
Priority to JP2002515900A priority patent/JP2004505087A/en
Priority to CA002417264A priority patent/CA2417264C/en
Priority to DK01951842T priority patent/DK1305314T3/en
Priority to UA2003010715A priority patent/UA72631C2/en
Priority to AU2001272690A priority patent/AU2001272690B2/en
Priority to GE5062A priority patent/GEP20053494B/en
Priority to CNB018133924A priority patent/CN1207297C/en
Priority to YU4703A priority patent/YU4703A/en
Priority to PE2001000746A priority patent/PE20020277A1/en
Priority to MYPI20013530A priority patent/MY117831A/en
Priority to UY26854A priority patent/UY26854A1/en
Priority to DO2001000217A priority patent/DOP2001000217A/en
Priority to PH12001001922A priority patent/PH12001001922B1/en
Priority to US09/915,705 priority patent/US6420557B1/en
Priority to ARP010103576A priority patent/AR032628A1/en
Priority to APAP/P/2001/002234A priority patent/AP1400A/en
Priority to TNTNSN01112A priority patent/TNSN01112A1/en
Priority to PA20018523501A priority patent/PA8523501A1/en
Priority to SV2001000570A priority patent/SV2001000570A/en
Priority to TW090118441A priority patent/TWI285643B/en
Priority to BG107266A priority patent/BG107266A/en
Priority to IS6626A priority patent/IS6626A/en
Priority to IN1649MU2002 priority patent/IN2002MU01649A/en
Priority to MA27003A priority patent/MA26931A1/en
Priority to NO20030416A priority patent/NO324220B1/en
Priority to HR20030061A priority patent/HRP20030061A2/en
Priority to EC2003004454A priority patent/ECSP034454A/en
Priority to ZA200301457A priority patent/ZA200301457B/en
Priority to HK03108198A priority patent/HK1055954A1/en
Ceased legal-status Critical Current

Links

GB0106464A 2000-07-28 2001-03-15 Crystalline therapeutic agent Ceased GB0106464D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent
IL15322601A IL153226A0 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
EEP200300045A EE200300045A (en) 2000-07-28 2001-07-18 Crystalline drug substance
NZ523226A NZ523226A (en) 2000-07-28 2001-07-18 Crystalline form of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine
DZ013364A DZ3364A1 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
SI200130283T SI1305314T1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
AU7269001A AU7269001A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
PL01365133A PL365133A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
OA1200300008A OA12337A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent.
CZ2003126A CZ2003126A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic formulation
KR20037001202A KR100457937B1 (en) 2000-07-28 2001-07-18 Crystalline Therapeutic Agent
AT01951842T ATE286901T1 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
PT01951842T PT1305314E (en) 2000-07-28 2001-07-18 CRYSTAL THERAPEUTIC AGENT
SK57-2003A SK572003A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
MXPA03000856 MX233602B (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent.
EP01951842A EP1305314B1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
EA200300079A EA004681B1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
PCT/IB2001/001280 WO2002010171A1 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
BR0112734-9A BR0112734A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
DE60108398T DE60108398T2 (en) 2000-07-28 2001-07-18 CRYSTALLINE THERAPEUTIC AGENT
HU0302982A HUP0302982A3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
ES01951842T ES2231521T3 (en) 2000-07-28 2001-07-18 CRYSTAL THERAPEUTIC AGENT.
JP2002515900A JP2004505087A (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
CA002417264A CA2417264C (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
DK01951842T DK1305314T3 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
UA2003010715A UA72631C2 (en) 2000-07-28 2001-07-18 Cryslalline therapeutical agent
AU2001272690A AU2001272690B2 (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
GE5062A GEP20053494B (en) 2000-07-28 2001-07-18 Crystalline Therapeutic Agent
CNB018133924A CN1207297C (en) 2000-07-28 2001-07-18 Crystalline therapeutic agent
YU4703A YU4703A (en) 2000-07-28 2001-07-18 Cristalline therapeutic agent
PE2001000746A PE20020277A1 (en) 2000-07-28 2001-07-24 POLYMORPH 1- {6-ETHOXY-5- [3-ETHYL-6,7-DIHYDRO-2- (2-METOXYETHYL) -7-OXO-2H-PYRAZOLO [4,3-d] PYRIMIDIN-5-IL] - 3-PYRIDYLSULFONIL} -4-ETHYLPIPERAZINE
MYPI20013530A MY117831A (en) 2000-07-28 2001-07-25 Crystalline therapeutic agent
UY26854A UY26854A1 (en) 2000-07-28 2001-07-26 CRYSTAL THERAPEUTIC AGENT
DO2001000217A DOP2001000217A (en) 2000-07-28 2001-07-26 CRYSTAL THERAPEUTIC AGENT
PH12001001922A PH12001001922B1 (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent.
US09/915,705 US6420557B1 (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent
ARP010103576A AR032628A1 (en) 2000-07-28 2001-07-26 POLYMORPH COMPOUND 1- {6-ETOXI-5- [3-ETIL-6,7-DIHYDRO-2- (2-METOXYETHYL) -7-OXO-2H-PIRAZOLO [4,3-D] PIRIMIDIN-5-IL ] -3-PIRIDILSULFONIL} -4-ETILPIPERAZINA
APAP/P/2001/002234A AP1400A (en) 2000-07-28 2001-07-26 Crystalline therapeutic agent.
TNTNSN01112A TNSN01112A1 (en) 2000-07-28 2001-07-27 CRYSTALLINE THERAPEUTIC AGENT
PA20018523501A PA8523501A1 (en) 2000-07-28 2001-07-27 CRYSTAL THERAPEUTIC AGENT
SV2001000570A SV2001000570A (en) 2000-07-28 2001-07-27 CRYSTAL THERAPEUTIC AGENT REF. PCS22011AFAE / BB
TW090118441A TWI285643B (en) 2000-07-28 2001-07-27 A polymorph of 1-{6-ethoxy-5-[3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-pyridylsulfonyl}-4-ethylpiperazine and a process for preparing the same
BG107266A BG107266A (en) 2000-07-28 2002-11-12 Crystalline therapeutic agent
IS6626A IS6626A (en) 2000-07-28 2002-11-18 Crystalline treatment agent
IN1649MU2002 IN2002MU01649A (en) 2000-07-28 2002-11-20
MA27003A MA26931A1 (en) 2000-07-28 2003-01-20 CRYSTALLINE THERAPEUTIC AGENT.
NO20030416A NO324220B1 (en) 2000-07-28 2003-01-27 Process for preparing a polymorph
HR20030061A HRP20030061A2 (en) 2000-07-28 2003-01-28 Crystalline therapeutic agent
EC2003004454A ECSP034454A (en) 2000-07-28 2003-01-28 CRYSTAL THERAPEUTIC AGENT
ZA200301457A ZA200301457B (en) 2000-07-28 2003-02-24 Crystalline therapeutic agent.
HK03108198A HK1055954A1 (en) 2000-07-28 2003-11-12 Crystalline therapeutic agent.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
GB0106464D0 true GB0106464D0 (en) 2001-05-02

Family

ID=9910783

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0106464A Ceased GB0106464D0 (en) 2000-07-28 2001-03-15 Crystalline therapeutic agent

Country Status (1)

Country Link
GB (1) GB0106464D0 (en)

Similar Documents

Publication Publication Date Title
GB0119152D0 (en) Therapeutic agents
GB0113841D0 (en) Therapeutic agents
GB0128885D0 (en) Therapeutic agents
GB0120347D0 (en) Therapeutic agents
GB0114867D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0113843D0 (en) Therapeutic agents
IL153226A0 (en) Crystalline therapeutic agent
GB0119370D0 (en) Therapeutic agent
GB0120345D0 (en) Therapeutic agents
GB0108982D0 (en) Therapeutic agents
GB0119803D0 (en) Therapeutic agents
GB0106464D0 (en) Crystalline therapeutic agent
GB0119828D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0108973D0 (en) Therapeutic agents
SI1305314T1 (en) Crystalline therapeutic agent
GB0108589D0 (en) Therapeutic agent
GB0116151D0 (en) Therapeutic agent
GB0125210D0 (en) Therapeutic agent
GB0128638D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)